Teladoc Health, Inc. - stock earnings
TDOC Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 23, 2024 AfterMarket | - / - | 633.9 million | - / 637.3 million | 644.1 million |
| July 23, 2024 BeforeMarket | - / - | 646.1 million | - / 653.8 million | 669.5 million |
TDOC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -81.9 million USD | 646.1 million USD |
| 2023Q4 | -28.9 million USD | 660.5 million USD |
| 2023Q3 | -57.1 million USD | 660.2 million USD |
| 2023Q2 | -65.2 million USD | 652.4 million USD |
| 2023Q1 | -69.2 million USD | 629.2 million USD |
| 2022Q4 | -3.8 billion USD | 637.7 million USD |
| 2022Q3 | -73.5 million USD | 611.4 million USD |
| 2022Q2 | -3.1 billion USD | 592.4 million USD |
| 2022Q1 | -6.7 billion USD | 565.4 million USD |
| 2021Q4 | -11.0 million USD | 554.2 million USD |
| 2021Q3 | -84.3 million USD | 521.7 million USD |
| 2021Q2 | -133.8 million USD | 503.1 million USD |
| 2021Q1 | -199.6 million USD | 453.7 million USD |
| 2020Q4 | -394.0 million USD | 383.3 million USD |
| 2020Q3 | -35.9 million USD | 288.8 million USD |
| 2020Q2 | -25.7 million USD | 241.0 million USD |
| 2020Q1 | -29.6 million USD | 180.8 million USD |
| 2019Q4 | -19.0 million USD | 156.5 million USD |
| 2019Q3 | -20.3 million USD | 138.0 million USD |
| 2019Q2 | -29.3 million USD | 130.3 million USD |
| 2019Q1 | -30.2 million USD | 128.6 million USD |
| 2018Q4 | -24.9 million USD | 122.7 million USD |
| 2018Q3 | -23.3 million USD | 111.0 million USD |
| 2018Q2 | -25.1 million USD | 94.6 million USD |
| 2018Q1 | -23.9 million USD | 89.6 million USD |
| 2017Q4 | -44.4 million USD | 77.1 million USD |
| 2017Q3 | -31.3 million USD | 68.7 million USD |
| 2017Q2 | -15.4 million USD | 44.6 million USD |
| 2017Q1 | -15.7 million USD | 42.9 million USD |
| 2016Q4 | -14.3 million USD | 37.4 million USD |
| 2016Q3 | -29.8 million USD | 32.4 million USD |
| 2016Q2 | -14.9 million USD | 26.5 million USD |
| 2016Q1 | -15.3 million USD | 26.9 million USD |
| 2015Q4 | -15.0 million USD | 22.6 million USD |
| 2015Q3 | -13.2 million USD | 20.0 million USD |
| 2015Q2 | -17.1 million USD | 18.3 million USD |
| 2015Q1 | -12.7 million USD | 16.5 million USD |
| 2014Q4 | -7.0 million USD | 12.9 million USD |
| 2014Q3 | -4.5 million USD | 10.9 million USD |
| 2014Q2 | -3.2 million USD | 10.3 million USD |
| 2014Q1 | -2.3 million USD | 9.4 million USD |
| 2013Q4 | ? USD | 19.9 million USD |
TDOC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -220.4 million USD | 2.6 billion USD |
| 2022 | -13.7 billion USD | 2.4 billion USD |
| 2021 | -428.8 million USD | 2.0 billion USD |
| 2020 | -485.1 million USD | 1.1 billion USD |
| 2019 | -98.9 million USD | 553.3 million USD |
| 2018 | -97.1 million USD | 417.9 million USD |
| 2017 | -106.8 million USD | 233.3 million USD |
| 2016 | -74.2 million USD | 123.2 million USD |
| 2015 | -58.0 million USD | 77.4 million USD |
| 2014 | -17.0 million USD | 43.5 million USD |
| 2013 | -6.0 million USD | 19.9 million USD |
TDOC
Price: $12.78
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -0.82
Exchange: NYQ
Sector: Healthcare
Industry: Health Information Services
Volume: 4.6 million
Ebitda: -15.1 millionMarket Capitalization: 2.2 billion